Papers

1

Total Citations

7

H-Index

1

About

Dr. Bin Ju is a leading immunologist whose research focuses on antibody responses to viral pathogens, particularly SARS-CoV-2 and its evolving variants. His major contributions lie in characterizing how emerging viral sub-lineages evade neutralizing antibodies, providing critical insights for vaccine and therapeutic design. In his highly cited 2023 study, "Striking antibody evasion of SARS-CoV-2 Omicron sub-lineages BQ.1.1, XBB.1 and CH.1.1," Dr. Ju demonstrated that these variants exhibit profound resistance to neutralization by both vaccine-induced and infection-acquired antibodies, highlighting the urgent need for updated countermeasures. This work has garnered 7 citations, reflecting its immediate impact on the scientific community's understanding of viral immune escape. Dr. Ju's research is instrumental in tracking the evolutionary trajectory of SARS-CoV-2 and informing public health strategies. His findings have been widely recognized for their timeliness and translational relevance, cementing his reputation as a key contributor to pandemic response efforts.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Striking antibody evasion of SARS-CoV-2 Omicron sub-lineages BQ.1.1, XBB.1 and CH.1.1
7 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: National Medical Products Administration

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago